For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Illumina Corporation

Calculating rank

USPTO Granted Patents = 1,227

% Expired Patents = 8.5

CIPO Patents = 27

EPO Patents = 415

Trademarks = 3

Forward Citations = 19,965

Loading Chart...

Loading Chart...

960 inventors (with patents filed for the assignee):

Kevin L Gunderson (94 out of 124 patents)

Tarun Kumar Khurana (79 out of 86 patents)

M Shane Bowen (73 out of 74 patents)

4. John A Moon (67 out of 88 patents)

5. Frank J Steemers (51 out of 55 patents)

6. Robert C Kain (51 out of 58 patents)

7. Mark S Chee (50 out of 188 patents)

8. Wenyi Feng (47 out of 48 patents)

9. Stanley Hong (47 out of 113 patents)

10. Erik Allegoren (43 out of 44 patents)

11. Jeffrey G Mandell (39 out of 44 patents)

12. Wayne N George (39 out of 51 patents)

13. Jeffrey S Fisher (38 out of 43 patents)

14. Min-Jui Richard Shen (38 out of 43 patents)

15. John R Stuelpnagel (38 out of 50 patents)

Core Competencies:

Nucleic Acid Sequencing

Single Cell Sequencing

Flow Cells

Base Calling

Hybridization Seals

Nanopore Sensors

Genomic DNA

AI-driven Technologies

Sample Identification

Microfluidic Structures

Therapeutic Agents

Polynucleotide Fragments

1,227 patents: Sort by Forward Citations

1. 12776389 - Graph reference genome and base-calling approach using imputed haplotypes (2026-10-27),

2. 12774492 - COMPOSITIONS AND METHODS FOR POLYNUCLEOTIDE SEQUENCING (2026-10-27),

3. 12773695 - FLOW CELLS AND METHODS FOR MAKING THE SAME (2026-10-27),

4. D1153781 - Sequencing instrument (2026-10-13),

5. 12763169 - Quality score compression (2026-10-13),

6. 12763166 - Specialist signal profilers for base calling (2026-10-13),

7. 12762151 - Variant pathogenicity scoring and classification and uses thereof (2026-10-13),

8. 12760363 - Sequencing and high resolution imaging (2026-10-13),

9. 12760356 - COMPOSITIONS AND METHODS FOR CAPTURING AND AMPLIFYING TARGET POLYNUCLEOTIDES USING MODIFIED CAPTURE PRIMERS (2026-10-13),

10. 12760138 - Barriers including cross-linked amphiphilic molecules, and methods of making the same (2026-10-13),

11. 12758966 - System and method for sequestered wash buffer reuse (2026-10-13),

12. 12755163 - Machine learning-based genotyping process outcome prediction using aggregate metrics (2026-10-06),

13. 12753433 - Methods and systems for encapsulating lyophilised microspheres (2026-10-06),

14. 12748294 - Substrates for performing quantification processes and related systems and methods (2026-09-29),

15. 12747471 - Circuit design to apply different voltages in a nanopore array (2026-09-29),

Company Overview

Illumina Corporation, headquartered in San Diego, CA, is a leader in the field of nucleic acid sequencing. The company specializes in developing innovative technologies for genomic analysis, including single cell sequencing and advanced flow cell systems. Illumina's core offerings encompass a range of applications, from base calling to hybridization seals and nanopore sensors, all aimed at enhancing genomic research and personalized medicine. The integration of AI-driven technologies further positions Illumina at the forefront of genomic advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

1,227 Patents

#3 in San Diego, CA

#103 in California

#417 in US

#835 in the World

San Diego, CA, United States of America

Illumina Corporation

Forward Citations = 19,965

960 inventors:

Kevin L Gunderson (94 out of 124 patents)

Tarun Kumar Khurana (79 out of 86 patents)

M Shane Bowen (73 out of 74 patents)

4. John A Moon (67 out of 88 patents)

5. Frank J Steemers (51 out of 55 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Illumina Corporation. Retrieved from https://idiyas.com/company/illumina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…